Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · IEX Real-Time Price · USD
3.120
+0.130 (4.35%)
At close: Apr 19, 2024, 4:00 PM
3.090
-0.030 (-0.96%)
After-hours: Apr 19, 2024, 6:45 PM EDT
Conduit Pharmaceuticals Statistics
Total Valuation
CDT has a market cap or net worth of $230.35 million. The enterprise value is $227.11 million.
| Market Cap | 230.35M |
| Enterprise Value | 227.11M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CDT has 73.83 million shares outstanding. The number of shares has increased by 81.30% in one year.
| Shares Outstanding | 73.83M |
| Shares Change (YoY) | +81.30% |
| Shares Change (QoQ) | +13.58% |
| Owned by Insiders (%) | 86.00% |
| Owned by Institutions (%) | 0.69% |
| Float | 18.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.18
| Current Ratio | 3.18 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -11.10% |
| Return on Capital (ROIC) | -996.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$178,333 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.12 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.53 |
| Average Volume (30 Days) | 34,243 |
Short Selling Information
The latest short interest is 55,109, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 55,109 |
| Short Previous Month | 77,766 |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.30% |
| Short Ratio (days to cover) | 1.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.26M |
| Pretax Income | -535,000 |
| Net Income | -535,000 |
| EBITDA | -324,000 |
| EBIT | -324,000 |
| Earnings Per Share (EPS) | -$6,056.00 |
Balance Sheet
The company has $4.23 million in cash and $985,000 in debt, giving a net cash position of $3.24 million or $0.04 per share.
| Cash & Cash Equivalents | 4.23M |
| Total Debt | 985,000 |
| Net Cash | 3.24M |
| Net Cash Per Share | $0.04 |
| Equity / Book Value | -457,000 |
| Book Value Per Share | -0.01 |
| Working Capital | 3.93M |
Cash Flow
| Operating Cash Flow | -7.73M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.73M |
| FCF Per Share | -$0.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CDT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -81.30% |
| Shareholder Yield | -81.30% |
| Earnings Yield | -0.23% |
| FCF Yield | -3.35% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |